Skip to main content
Log in

Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency

  • Originals
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

D-ribose was administered orally or intravenously over at least 5 h to eight healthy volunteers and five patients with myoadenylate deaminase deficiency. Intravenous administration rates were 83, 167, and 222 mg/kg/h, which were well tolerated but oral administration of more than 200 mg/kg/h caused diarrhea. The average steady state serum ribose level ranged between 4.8 mg/100 ml (83 mg/kg/h, oral administration) and 81.7 mg/100 ml (222 mg/kg/h, intravenous administration). Serum glucose level decreased during ribose administration. The intestinal absorption rate of orally administered ribose was 87.8%–99.8% of the intake at doses up to 200 mg/kg/h without first pass effect. Urinary losses were 23% of the intravenously administered dose at 222 mg/kg/h. Ribose appeared to be excreted by glomerular filtration without active reabsorption; a renal threshold could not be demonstrated. The amount of ribose transported back from the tubular lumen depended on the serum ribose level. There was no difference in ribose turnover in healthy subjects and patients with MAD deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

MAD:

myoadenylate deaminase

i.v.:

intravenous(ly)

References

  1. Beaconsfield P, Ginsburg J (1967) Hypoglycaemia after oral ribose. Lancet 2:153

    Google Scholar 

  2. Bierman EL, Baker EM, Plough I, Hall WH (1959) Metabolism of D-ribose in diabetes mellitus. Diabetes 8:455–458

    Google Scholar 

  3. DiMauro S, Miranda AF, Hays AP, Franck WA, Hoffman GS, Schoenfeldt RS, Singh N (1980) Myoadenylate deaminase deficiency. Muscle biopsy and muscle culture in a patient with gout. J Neurol Sci 47:191–202

    Google Scholar 

  4. Fishbein WN, Griffin JL, Armbrustmacher VW (1980) Stain for skeletal muscle adenylate deaminase. An effective tetrazolium stain for frozen biopsy specimens. Arch Pathol Lab Med 104:462–466

    Google Scholar 

  5. Futterman S, Roe JH (1955) The identification of ribulose and l-xylulose in human and rat urine. J Biol Chem 215:257

    Google Scholar 

  6. Ginsburg J, Boucher B, Beaconsfield P (1969) Mechanism of ribose-induced hypoglycaemia. Acta Endocrinol, S 138–158

  7. Ginsburg J, Boucher B, Beaconsfield P (1970) Hormonal changes during ribose-induced hypoglycemia. Diabetes 19:13–27

    Google Scholar 

  8. Goodman C, Goetz FC (1970) Oral and intravenous D-ribose and plasma insulin in healthy humans: effects of route of administration and of epinephrine and propanolol. Metabolism 19:1094–1103

    Google Scholar 

  9. Heuckenkamp PU, Zöllner N (1970) Über das Verhalten von Galaktose, Glucose, Insulin und der freien Fettsäuren im Plasma sowie der renalen Ausscheidung von Galaktose und Glucose während mehrstündiger Galaktoseinfusion beim Menschen. Z Ges Exp Med 153:136–149

    Google Scholar 

  10. Heuckenkamp PU (1973) Zur Bilanz parenteral zugeführter Kohlenhydrate. Verhandlungen der 28. Tagung der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten, Erlangen

  11. Heuckenkamp PU (1974) Vergleichende Untersuchungen über die Verwertung parenteral zugeführter Kohlenhydrate während mehrstündiger Infusion beim Menschen. Melsunger Medizinische Mitteilungen, Bd 48, Suppl I, 149–160

    Google Scholar 

  12. Heuckenkamp PU, Zöllner N (1975) Quantitative comparison and evaluation of utilization of parenteral administered carbohydrates. Nutr Metabol 18 [Suppl 1]:209–226

    Google Scholar 

  13. Hiatt HH (1957) The pentose phosphate pathway in human metabolism. J Clin Invest 36:899

    Google Scholar 

  14. Hiatt HH (1958) Studies of ribose metabolism. III. The pathway of ribose carbon conversion to glucose in man. J Clin Invest 37:651–654

    Google Scholar 

  15. Marini M, Zunica G, Franceschi C (1985) Inhibition of cell proliferation by D-ribose and deoxy-D-ribose. Proc Soc Exp Biol Med 180:246–257

    Google Scholar 

  16. Miller B (1974) Der D-Xylose-Test. In: Englhardt A, Lommel H (Hrsg) Malabsorption. Maldigestion. Band 2. Weilheim, S 155–163

  17. Pizzichini M, Micheli V, Marcolongo R, Marinello E (1978) Metabolismo del riboso nell'uomo. Boll Soc Biol Sper 54:420–424

    Google Scholar 

  18. Pizzichini M, Marcolongo R, Marinello E (1979) Ribose tolerance in gouty patients. J Clin Chem Clin Biochem 17:436

    Google Scholar 

  19. Pizzichini M, Marcolongo R, Marinello E (1980) Ribose tolerance in gouty patients. Purine metabolism in man. In: Rapado A, Watts RWE, DeBruyn CHMM (eds) III Biochemical, immunological and cancer research, Part A. Plenum Press, London, pp 81–86

    Google Scholar 

  20. Roe JH, Rice EW (1948) A photometric method for the determination of free pentoses in animal tissues. J Biol Chem 173:507–512

    Google Scholar 

  21. Segal S, Foley J, Wyngaarden JB (1957) Hypoglycemic effect of d-ribose in man. Proc Soc Exp Biol 95:551–555

    Google Scholar 

  22. Segal S, Foley J (1958) The metabolism of d-ribose in man. J Clin Invest 37:719–735

    Google Scholar 

  23. Stankova J, Rola-Plesczynski M (1984) Alpha-fucose inhibits human mixed-lymphocyte culture reactions and subsequent suppressor cell generation. Cell Immunol 83:83–91

    Google Scholar 

  24. Steinberg T, Ortman P, Poucher R, Cochran B Jr, Gwinup G (1967) The effect of d-ribose infusion on serum immunoreactive insulin and glucose concentration. Metabolism 16:40–46

    Google Scholar 

  25. Steinberg T, Poucher RI, Sarin RK, Rees RB, Gwinup G (1970) Oral administration of D-ribose in diabetes mellitus. Diabetes 19:11–16

    Google Scholar 

  26. Touster O, Hutcheson RM, Reynolds VH (1954) The formation of l-xylulose in mammals and its utilization by liver preparations. J Am Chem Soc 76:5005–5006

    Google Scholar 

  27. Tower DB, Peters EL, Pogorelskin MA (1956) Nature and significance of pentosuria in neuromuscular diseases. Neurology 6. 37:125–142

    Google Scholar 

  28. Ulrich F (1983) Inhibition by specific monosaccharides of interleukin 2-induced thymocyte proliferation. Cell Immunol 80:241–256

    Google Scholar 

  29. White AA, Hess WC (1956) Paper chromatographic detection of sugars in normal and dystrophic human urines. Arch Biochem Biophys 64:57

    Google Scholar 

  30. Wuest HM, Solmssen UV (1946) The urinary excretion of d-ribose in man. Arch Biochem 11:199–201

    Google Scholar 

  31. Zimmer HG, Ibel H (1984) Ribose accelerates the repletion of the ATP pool during recovery from reversible ischemia of the rat myocardium. J Mol Cell Cardiol 16:863–866

    Google Scholar 

  32. Zöllner N, Heuckenkamp PU, Nechwatal W (1968) Über die Verwertung und renale Ausscheidung von Fructose während ihrer langdauernden intravenösen Zufuhr. Klin Wochenschr 46:1300–1308

    Google Scholar 

  33. Zöllner N, Gross M (1986) Myoadenylatedeaminase-Mangel. Erfolgreiche Therapie eines Falles mit Ribose bzw. Xylit. Klin Wochenschr 64 [Suppl V]:34–35

    Google Scholar 

  34. Zöllner N, Reiter S, Gross M, Pongratz D, Reimers CD, Gerbitz K, Paetzke I, Deufel T, Hübner G (1986) Myodenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose. Klin Wochenschr 64:1281–1290

    Google Scholar 

  35. Zunica G, Marini M, Brunelli MA, Chiricolo M, Franceschi C (1986) D-Ribose inhibits DNA repair synthesis in human lymphocytes. Biochem Biophys Res Commun 138:6763–6778

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gross, M., Reiter, S. & Zöllner, N. Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency. Klin Wochenschr 67, 1205–1213 (1989). https://doi.org/10.1007/BF01716208

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01716208

Key words

Navigation